Home

Results 31 - 40 of 158,484 for medicinal advantages. Search took 4.268 seconds.  
Sort by date/Sort by relevance
Combating counterfeiting is a challenge for Russia • Illegal (non-certified) communication devices (about 15% of the market) • Stolen phones • Counterfeit medicines • Luxury goods Combating counterfeiting is vital for the economy and well-being of all citizens! Requirements for Identification Systems • Resistance to duplication and cloning • Traceability • Applicable for Identification of goods and ICT devices • Easy of use QR-code Advantages Disadvantages QR-code + Can be used for identification of goods + Can be scanned by mobile phones − Easily can be changed − Cannot be used for identification of mobile devices − Сan be erased (physically removed) NFC, RFID + Can be used for identification of goods + Can be scanned by mobile phones + It is possible to process many identifiers simultaneously located in the range of the reader − Can be intercepted and cloned to the counterfeit goods − Not appropriate for identification of mobile devices Device Fingerprint + Difficult to fake + Wide area of use (smartphones, laptops, PCs …) + Works even when cookies can't be read or stored in the browser, or the client IP address is hidden − Complicated and require a lot of computation resources − Cannot be used for identification of goods − User privacy issues Identification based on IMEI + Already embedded in mobile phones (widely spread) + Easy to deploy − IMEI can be changed easily − Cannot be used for identification of goods 1 the share of devices with "zero" or duplicated IMEI in "Rostelecom" network is about 10%. (...) (IMEI, QR-code, RFID, IP, MAC, …) GHR LHR LHR LHR LHR Use Case: Combating Counterfeit Medicines Parameter Value DOA 10.1525/59.5.9 Unique number 35-209900-176148-1 Picture of the original box Global Handle Registry (GHR) Local Handle Registry (LHR) Access Point 1 2 3 4 INTERNET Pharmaceutical Factory 1 2 3 On the box with medicine applied NFS tag, which can be read using a smartphone or local NFС-reader in the pharmacy 4 The Factory makes an entry with the value HANDLE + unique information in the LHR To verify the authenticity of the medicine, a request is sent to the GHR.
Language:English
Score: 1175115.7 - https://www.itu.int/en/ITU-T/W...ts/6_Rustam%20Pirmagomedov.pdf
Data Source: un
The Resolution recognizes access to medicines in the context of pandemics as an essential human right. (...) Some of the elements in Article 7 are particularly relevant, in order to ensure that the provisions of TRIPS do not conflict with health policies: the promotion of technological innovation and the transfer and dissemination of technology; the mutual advantage of producers and users of technological knowledge; social and economic welfare; and the balance of rights and obligations.  19. (...) In the context of health policies, for instance, patent rights should be exercised coherently with the objectives of mutual advantage of patent holders and the users of patented medicines, in a manner conducive to social and economic welfare and to a balance of rights and obligations.
Language:English
Score: 1171484.8 - https://www.wto.org/english/tr...ips_e/paper_develop_w296_e.htm
Data Source: un
Organic Agriculture: Asia (Bhután, India, Nepal y Sri Lanka) العربية 中文 english français Español Página principal de la FAO Agricultura Orgánica Inicio Mandatos e Informes Glosario Foro (ORCA) Publicaciones Noticias destacadas Datos de los Países Eventos Proyectos Enlaces relacionados Preguntas frecuentes sobre agricultura orgánica Contacto Asia (Bhután, India, Nepal y Sri Lanka)   Asia (Bhután, India, Nepal y Sri Lanka) Title : Organic Production of Underutilized Medicinal, Aromatic and Natural Dye Plants Programme for Sustainable Rural Livelihoods in South Asia Objective : The overall objective of the Programme is to sustainably improve the livelihoods of the rural poor in South Asia through the development of diversified production chains for organically produced Medicinal, Aromatic and Natural Dye Plants (MADPs) and certified collected MADPs. (...) The specific purposes of the Programme are to: empower the rural poor and rural communities through participatory involvement, training and equitable benefit distribution, including fair trade principles, in all MADP and related organic production processes and outputs; develop, strengthen and test the full production chain for organic MADP products from production, collection and value-adding to certification, market research and marketing through appropriate small and medium enterprises (SMEs), non-governmental organizations (NGOs) and information and communication networks; and develop, implement and test/verify a fully transparent and traceable quality management programme with certification for organic production, responsible collection and other highquality international trade parameters to enable long-term marketing advantages, including export and local health care.    
Language:English
Score: 1168700.2 - https://www.fao.org/organicag/...rust-fund-projects/oa-asia/es/
Data Source: un
Organic Agriculture: Asie (Bhoutan, Inde, Népal et Sri Lanka) العربية 中文 english français Español Accueil de la FAO Agriculture Biologique Accueil Mandats et rapports Glossaire Forum (ORCA) Publications Rubriques spéciales Données Pays Événements Projets Liens Connexes Questions fréquemment posées sur l'agriculture biologique Contact Asie (Bhoutan, Inde, Népal et Sri Lanka)   Asie (Bhoutan, Inde, Népal et Sri Lanka) Title : Organic Production of Underutilized Medicinal, Aromatic and Natural Dye Plants Programme for Sustainable Rural Livelihoods in South Asia Objective : The overall objective of the Programme is to sustainably improve the livelihoods of the rural poor in South Asia through the development of diversified production chains for organically produced Medicinal, Aromatic and Natural Dye Plants (MADPs) and certified collected MADPs. (...) The specific purposes of the Programme are to: empower the rural poor and rural communities through participatory involvement, training and equitable benefit distribution, including fair trade principles, in all MADP and related organic production processes and outputs; develop, strengthen and test the full production chain for organic MADP products from production, collection and value-adding to certification, market research and marketing through appropriate small and medium enterprises (SMEs), non-governmental organizations (NGOs) and information and communication networks; and develop, implement and test/verify a fully transparent and traceable quality management programme with certification for organic production, responsible collection and other highquality international trade parameters to enable long-term marketing advantages, including export and local health care.    
Language:English
Score: 1168700.2 - https://www.fao.org/organicag/...rust-fund-projects/oa-asia/fr/
Data Source: un
Organic Agriculture: Sudeste de Asia (Myanmar, Tailandia, Malasia) العربية 中文 english français Español Página principal de la FAO Agricultura Orgánica Inicio Mandatos e Informes Glosario Foro (ORCA) Publicaciones Noticias destacadas Datos de los Países Eventos Proyectos Enlaces relacionados Preguntas frecuentes sobre agricultura orgánica Contacto Sudeste de Asia (Myanmar, Tailandia, Malasia)   Sudeste de Asia (Myanmar, Tailandia, Malasia) Title : Organic Production of Underutilized Medicinal, Aromatic and Natural Dye Plants Programme for Sustainable Rural Livelihoods in South Asia Objective : The overall objective of the Programme is to sustainably improve the livelihoods of the rural poor in South Asia through the development of diversified production chains for organically produced Medicinal, Aromatic and Natural Dye Plants (MADPs) and certified collected MADPs. (...) The specific purposes of the Programme are to: empower the rural poor and rural communities through participatory involvement, training and equitable benefit distribution, including fair trade principles, in all MADP and related organic production processes and outputs; develop, strengthen and test the full production chain for organic MADP products from production, collection and value-adding to certification, market research and marketing through appropriate small and medium enterprises (SMEs), non-governmental organizations (NGOs) and information and communication networks; and develop, implement and test/verify a fully transparent and traceable quality management programme with certification for organic production, responsible collection and other highquality international trade parameters to enable long-term marketing advantages, including export and local health care.    
Language:English
Score: 1168700.2 - https://www.fao.org/organicag/...-projects/oa-southeastasia/es/
Data Source: un
Organic Agriculture: Asie du Sud-Est (Myanmar, Thaïlande, Malaisie) العربية 中文 english français Español Accueil de la FAO Agriculture Biologique Accueil Mandats et rapports Glossaire Forum (ORCA) Publications Rubriques spéciales Données Pays Événements Projets Liens Connexes Questions fréquemment posées sur l'agriculture biologique Contact Asie du Sud-Est (Myanmar, Thaïlande, Malaisie)   Asie du Sud-Est (Myanmar, Thaïlande, Malaisie) Title : Organic Production of Underutilized Medicinal, Aromatic and Natural Dye Plants Programme for Sustainable Rural Livelihoods in South Asia Objective : The overall objective of the Programme is to sustainably improve the livelihoods of the rural poor in South Asia through the development of diversified production chains for organically produced Medicinal, Aromatic and Natural Dye Plants (MADPs) and certified collected MADPs. (...) The specific purposes of the Programme are to: empower the rural poor and rural communities through participatory involvement, training and equitable benefit distribution, including fair trade principles, in all MADP and related organic production processes and outputs; develop, strengthen and test the full production chain for organic MADP products from production, collection and value-adding to certification, market research and marketing through appropriate small and medium enterprises (SMEs), non-governmental organizations (NGOs) and information and communication networks; and develop, implement and test/verify a fully transparent and traceable quality management programme with certification for organic production, responsible collection and other highquality international trade parameters to enable long-term marketing advantages, including export and local health care.    
Language:English
Score: 1168700.2 - https://www.fao.org/organicag/...-projects/oa-southeastasia/fr/
Data Source: un
TDR | New open access database to spur development of medicines for infectious diseases of the developing world Skip to main content Access Home Alt+0 Navigation Alt+1 Content Alt+2 Search Search the WHO .int site Submit Advanced search Navigation Home News About us Research for implementation Strengthening Research Capacity Grants Publications & resources Global Engagement and Partnerships Diseases & topics Research on neglected priority needs, including product R&D, evaluation in real life settings, and increasing access to new tools Developing research leadership through education, training, networks and quality management Assessing global research needs and priorities, providing knowledge management and support for partner coordination All the calls for research and training grants, career development fellowships and how to apply Read, download or order TDR's publications and multimedia resources For the latest news, press releases and TDR events For more on TDR's strategy, governance, history and to find our staff For more on TDR partnerships and networks Menu News Latest news New open access database to spur development of medicines for infectious diseases of the developing world Comprehensive information will spur development of medicines TDR press release 16 April 2007 GENEVA - An international network of researchers announced today the release of a new web-based resource designed to facilitate the development of medicines to fight infectious diseases afflicting the developing world. (...) The database also takes advantage of genomic-scale datasets made publicly available by genome sequencing centers and other researchers around the world. The network encourages the international community to take advantage of this resource, contribute additional data, and make suggestions for further improvement.
Language:English
Score: 1164476.6 - https://www.who.int/tdr/news/2007/open-access-database/en/
Data Source: un
The Resolution recognizes access to medicines in the context of pandemics as an essential human right. (...) Some of the elements in Article 7 are particularly relevant, in order to ensure that the provisions of TRIPS do not conflict with health policies: the promotion of technological innovation and the transfer and dissemination of technology; the mutual advantage of producers and users of technological knowledge; social and economic welfare; and the balance of rights and obligations.  19. (...) In the context of health policies, for instance, patent rights should be exercised coherently with the objectives of mutual advantage of patent holders and the users of patented medicines, in a manner conducive to social and economic welfare and to a balance of rights and obligations.
Language:English
Score: 1163107.3 - https://www.wto.org/french/tra...ips_f/paper_develop_w296_f.htm
Data Source: un
The Resolution recognizes access to medicines in the context of pandemics as an essential human right. (...) Some of the elements in Article 7 are particularly relevant, in order to ensure that the provisions of TRIPS do not conflict with health policies: the promotion of technological innovation and the transfer and dissemination of technology; the mutual advantage of producers and users of technological knowledge; social and economic welfare; and the balance of rights and obligations.  19. (...) In the context of health policies, for instance, patent rights should be exercised coherently with the objectives of mutual advantage of patent holders and the users of patented medicines, in a manner conducive to social and economic welfare and to a balance of rights and obligations.
Language:English
Score: 1163107.3 - https://www.wto.org/spanish/tr...ips_s/paper_develop_w296_s.htm
Data Source: un
Nazeem Mohamed_ FEAPM_Market Access_02032018 Bonn.pptx THE AFRICAN MEDICINES REGULATORY HARMONIZATION INITIATIVE (AMRH) Nazeem Mohamed Chairman - Federation of East African Pharmaceutical Manufacturers (FEAPM) Vice Chair – Federation of African Pharmaceutical Manufacturers Ass. (...) Currently, 85% of Sub-Saharan Africa is implementing registration harmonization process AMRH Programme Overview EAC ECCAS/OCEAC SADC AMRH: Core Partners and Roles 5 EAC Medicines Regulation Harmonization Programme Launched on 30th March 2012 Purpose: Increase access to good quality, safe and effective medicines Expected outcomes: • Harmonized Guidelines and Procedures implemented by NMRAs • Integrated Information Management System (IMS) implemented • Quality Management System (QMS) implemented by all NMRAs • Regional and national capacity to implement EAC MRH • A platform for information sharing created • Framework for mutual recognition of regulatory decision developed and implemented MRH: Stepwise Approach Regional regulatory platforms Harmonized standards (technical requirements / guidelines) Joint and regional dossier assessments /GMP inspections Work sharing / pooling of resources Streamlined decision-making processes Reduced registration cycle time... ...starting with generics ...extending to other product categories (NCEs, vaccines, diagnostics) Extending to other regulatory functions over time (clinical trials, safety surveillance, etc.) Extending to other African regional blocs T h e P a th w a y 7 EAC: MRH Targets EAC guidelines implemented by year 3 Registration targets • 18 products registered through joint assessments • 75 products registered by TFDA (Tanzania Mainland), NDA (Uganda) and PPB (Kenya) • 50 products registered by ZFDB (Tanzania Zanzibar), DPML (Burundi) and MOH-PTF (Rwanda) Capacity built at NMRAs • Assessors, GMP Inspectors trained EAC Procedure for Marketing Authorization established and functional since January, 2015 32 applications received for joint assessment; 27 evaluated 23 queried and 4 products registered Joint GMP inspections conducted; 5 facilities approved Assessors & GMP Inspectors trained On going joint activities Harmonized requirements approved by Council of Ministers in Sept, 2014; • Registration, GMP and QMS • Effective from 1st Jan. 2015; • Adopted by all EAC NMRAs Centre of excellence established • MER – TFDA (TZ) • GMP – NDA (UG) • Pharmacovigilance – PPB (KE) Information Mgt System functional at TFDA Ongoing installation to other NMRAs MRH Progress to Date Approval process still lengthy, although median time down to 7 months from 12 months Joint evaluation of applications: ongoing, but slow Varied capacity in terms of infrastructure, financial and human resources among EAC RAs Poor quality dossiers and delayed/partial responses from applicants Increased cost for domestic applicants List of priority products for registration prepared by EAC and NMRAs favoured products from outside the EA region MRH: Challenges Observed Quick access to one Regional market More attractive for potential investors (40-60% reduction in approval times for foreign brands) More locally manufactured products registered (however, this is not yet the case) Joint medicinal product dossier assessments, GMP inspections and electronic submissions – saves time and scarce resources Industry responds to ONE set of queries from evaluated dossiers No need to prepare for individual NMRA’s inspection MRH: Expected Advantages Thank you
Language:English
Score: 1158894.2 - https://www.unido.org/sites/de...ccess_02032018%20Bonn.pptx.pdf
Data Source: un